Skip to main content
Clinical Trials/NCT00201656
NCT00201656
Terminated
Phase 4

Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial

Obstetrix Medical Group22 sites in 1 country58 target enrollmentNovember 2004

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Fetal Membranes, Premature Rupture
Sponsor
Obstetrix Medical Group
Enrollment
58
Locations
22
Primary Endpoint
Latency
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

Detailed Description

The placement of cervical cerclage is standard of care for women who experience incompetent cervix. Treadwell et al, published the largest retrospective review of 482 patients receiving cerclage (364 elective and 118 emergent). They found premature rupture of membranes (PROM) in 38% of the subjects with 9% delivering \<27 weeks. Preterm birth is the cause of at least 75% of neonatal deaths that are not due to congenital malformations. The question of whether to remove cerclage after preterm premature rupture of membranes (PPROM) is one of the unresolved controversies in obstetrics because the few available studies are retrospective, all have small numbers of patients, and the studies have given conflicting results regarding the safety of retaining a cerclage after preterm premature rupture of the membranes. It is unclear from the retrospective studies whether latency (the interval from membrane rupture to the onset of labor) is prolonged with retention of the suture. Furthermore, some, but not all studies suggest an increase in major infectious maternal morbidity and possibly neonatal morbidity. For this reason, clinicians vary greatly in deciding on whether to remove a cerclage in a patient with PPROM and either practice is currently an acceptable standard. This is a fairly rare complication, the combination of PPROM in a patient with cerclage in place only occurs in about 1-3/1000 pregnant women. Thus it has been impossible to study this problem prospectively in any single institution. The establishment of the Obstetrix Collaborative Research Group affords the unique opportunity to study this rare complication. Obstetrix manages 19 practices of Perinatologists around the U.S. and Mexico and is comprised of nearly 100 such subspecialists. This problem is most often referred to a Perinatologist when it occurs, so it is not unusual for these practices to see 5 - 10 such patients per year. Obstetrix fully funds the infrastructure of this research group and inclusion in this study will not alter the cost of patient care in either group as there is virtually no cost in removing the cerclage and all these patients are kept in hospital until delivery when membranes rupture as standard of care. This is a multicenter trial. The purpose is to determine whether retention of cerclage after preterm premature rupture of the membranes improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

Registry
clinicaltrials.gov
Start Date
November 2004
End Date
April 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Obstetrix Medical Group
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A previously placed prophylactic cerclage defined as any cerclage done \< 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation \< 3 cm
  • Spontaneous rupture of membranes 22-32 weeks
  • Singleton or twin gestation
  • Shirodkar or McDonald cerclage in place \> 1 week

Exclusion Criteria

  • Active labor (\> 8 uterine contractions \[UCs\] per hour)
  • Chorioamnionitis as defined by temperature \> 38 plus fetal tachycardia or uterine tenderness
  • Placenta previa or undiagnosed vaginal bleeding
  • Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)
  • Mature pulmonary studies
  • Positive gram stain, culture, white blood cells (WBC) \> 30, or glucose \< 14 on amniocentesis
  • Major fetal anomaly
  • Presentation \> 48 hours after rupture of membranes
  • abdominal cerclage
  • Cerclage done for symptomatic cervical dilation (cervix dilated \> 3 cm)

Outcomes

Primary Outcomes

Latency

Time Frame: labor to delivery

Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness

Time Frame: conception to birth

Grade 3 or 4 intraventricular hemorrhage

Time Frame: birth to 28days of life

Stage 2 or 3 necrotizing enterocolitis

Time Frame: birth to 28days of life

Neonatal intensive care unit (NICU) stay

Time Frame: birth to 28days of life

Birth weight

Time Frame: at birth

Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal death

Time Frame: Birth to 28days of life

Respiratory distress syndrome

Time Frame: birth to 28days of life

Documented sepsis within 72 hours of delivery

Time Frame: birth to 72 hours after delivery

Estimated gestational age (EGA) at delivery

Time Frame: at delivery

Postpartum endometritis

Time Frame: birth to 28days of life

Maternal sepsis

Time Frame: birth to 28days following delivery

Study Sites (22)

Loading locations...

Similar Trials